China Boton Group Company Limited Overview
China Boton is a Shenzhen-rooted, Hong Kong-listed mid-cap. It combines a legacy flavours-and-fragrances franchise with an e-cigarette hardware and e-liquid manufacturing platform. It sells tobacco flavours (formerly reported as "flavor enhancers") to PRC cigarette manufacturers, food flavours, and fine fragrances for personal and home care. Through the 2016 Kimree acquisition it designs and manufactures disposable and rechargeable e-cigarettes, e-liquids and accessories for tobacco companies and independent brand owners. A small Shenzhen investment-property portfolio supplies rental income. The group is founder-controlled: Mr. Wang Ming Fan holds 67.5%. Since 2022 it has been squeezed by PRC e-cigarette nationalisation of standards and by structural erosion in tobacco-flavour demand. That erosion forced an RMB845.4m goodwill write-down in FY2025. The 2025–26 RMB2.49bn Shenzhen land resumption has transformed the balance sheet. The investment question is now whether management can redeploy that windfall into a scaled, compliant vaping and flavour platform.
Company's own description (FY2025 Annual Report and H1 2026 Interim Results)
The FY2025 Annual Report describes the Group as principally engaged in manufacturing and selling extracts, flavours and fragrances, and also in designing and manufacturing high-quality electronic cigarettes and related products. It describes itself as one of the major flavours and fragrances manufacturers in the PRC. Its flavour products go to manufacturers in tobacco, beverages, daily foods, preserved food, savoury and confectionery. Its fragrance products go to manufacturers of cosmetics, perfumes, soaps, toiletries, hair care, deodorants, detergents and air fresheners. Its e-cigarette products (disposables, rechargeables and accessories) are sold to tobacco companies, independent e-cigarette makers and other customers under various brands, with end users across many countries.
The H1 2026 Interim Results reorder this description so that e-cigarettes come first. The group now describes itself as principally engaged in design, manufacture and distribution of e-cigarettes and related products, plus production and sale of tobacco flavours, and only then extracts, flavours and fragrances. It also stresses its portfolio of valid PRC e-cigarette licences as evidence of full-chain regulatory standing.
Business and revenue model
| Dimension | Characterisation | Evidence |
|---|---|---|
| Product vs service mix | Almost entirely product sales recognised at a point in time, plus rental income. FY2025: sales of goods RMB1,436.4m (96.0%), rental RMB59.2m (4.0%). | FY2025 Results, revenue by category |
| Subscription / licensing | None disclosed | — |
| Customer model | B2B. Tobacco flavours go to PRC cigarette manufacturers, which operate under the China National Tobacco monopoly. E-cigarettes are OEM/ODM and branded supply to tobacco companies and independent brand owners. F&F goes to FMCG manufacturers. | FY2025 Annual Report MD&A |
| Credit terms | 30–360 days. Trade receivables over one year were RMB269.2m at 30 Jun 2026, against an ECL provision of RMB242.2m. | H1 2026 Interim, Note 9 |
| Value-chain position | Mid-stream formulator and manufacturer. It buys aroma chemicals and natural raw materials (raw materials and consumables were RMB946.3m in FY2025, about 85% of cost of sales). For e-cigarettes it manufactures devices and e-liquids under PRC State Tobacco Monopoly Administration licences. | FY2025 Results, expenses by nature |
| End-markets | Tobacco (combustible flavouring and next-generation vapour), food and beverage, personal and home care, and Shenzhen commercial property | Segment reporting |
Independent characterisation
China Boton is best understood as two economically distinct businesses under one controlling family, with a property option attached.
The first is the cash-generative but shrinking PRC tobacco-flavour franchise. It depends on procurement decisions by provincial China Tobacco industrial companies. Management cited changes in major customers' demand, procurement-policy adjustments and customers' self-developed flavours as causes of the FY2025 36.2% revenue collapse. This business still carries most of the group's acquired intangibles and debt-service burden.
The second is a sub-scale, loss-making e-cigarette contract manufacturer. Its revenue roughly halved between FY2021 (RMB1,213.4m) and FY2024 (RMB639.6m), after PRC flavour bans and the national standard took effect on 1 October 2022. In H1 2026 revenue rebounded 58.1% on diversification of domestic customers.
The steady food-flavour and fine-fragrance segments, run largely through 69.1%-owned (pre-March 2026) Dongguan Boton, earn 24–31% pre-tax margins. They are the quiet profit engine.
Finally, the Shenzhen landbank has repeatedly been the most valuable asset. Its resumption for the Xili high-speed rail hub produced RMB2.49bn of cash compensation, set against a book value of only RMB113.9m.
Strategy
Stated strategic themes (FY2025 Annual Report and H1 2026 Interim, paraphrased)
-
Restore domestic position while accelerating globalisation, with a focused expansion into developing economies through localisation and technical cooperation.
-
Recalibrated growth drivers for tobacco and e-cigarettes. Management says the industry has moved from channel expansion to three priorities: (i) compliance capability with stringent global regulation; (ii) technology and product strength; and (iii) market diversification to reduce single-market reliance.
-
Upgrade production technologies and pursue partnerships with leading international enterprises to capture high-value-added markets. This includes aligning Chinese fragrance standards with global benchmarks.
-
Comprehensive international sales plans, especially for e-cigarettes, e-liquids and devices, with broader distribution and better customer service.
-
Automation and digital transformation to cut direct labour costs and better read customer trends.
-
Deploy land resumption proceeds to strengthen liquidity and working capital, enhance R&D, and expand the e-cigarette segment.
-
Corporate culture. Branded as "Four Transforms and Five Attitudes", with core values described as high technology, high quality, high outset and high standard.
Strategic initiatives in the last 24 months
| Initiative | Date | Detail | Status |
|---|---|---|---|
| Huizhou e-vaporiser intelligent manufacturing base (phase 2) | 2023–2025 | About RMB400m fixed-asset investment on 54,533 sqm | Completed in 2025; ramping |
| Shenzhen land resumption | Dec 2025 – Jul 2026 | RMB2,494.4m compensation received in full | Completed July 2026 |
| Use of proceeds | Dec 2025 plan | About RMB1,250m to repay bank borrowings; about RMB518.4m for working capital (per FilingReader summary) | Debt reduced by RMB1,037.5m in H1 2026 |
| Shanghai R&D base (Shanghai Longyin) | 30 Jun 2026 | RMB240m for 100% of a company owning a 61,039 sqm Fengxian industrial building. Eliminates rent and creates an alternative R&D and expansion base after the Shenzhen surrender. | RMB160m paid; completion pending |
| Share repurchases | May 2026 – ongoing | 25.818m shares in treasury by 11 Sep 2026 | Ongoing |
| Dongguan Boton profit guarantee extension | 1 Aug 2025 | Net profit growth of at least 5% for 1 Jan 2025 – 31 Mar 2026 | Fulfilled; 15.9% transfer completed |
| Negotiations with "several significant companies" on e-cigarette cooperation | H1 2026 | Counterparties not named | Unconfirmed |
| Southeast Asia e-liquid and device promotion | 2025–2026 | Reformed marketing division | Ongoing |
| ESG / sustainability | Annual | Annual ESG report; stated alignment with green economy, decarbonisation and resilience | No quantified targets disclosed |
| Cost programmes | 2024–2026 | Automation to reduce labour costs | No quantified targets disclosed |
Medium-term financial targets
Not publicly disclosed. The company does not issue numerical guidance or medium-term targets.
Products & Services
China Boton's filings describe products at category level. They do not disclose SKU-level brands, specifications or price lists. The catalogue below is built from disclosed categories; items not disclosed are flagged as such.
Tobacco flavors segment
| Product line | Description | Target customer | Launch / version | Pricing | Flagship |
|---|---|---|---|---|---|
| Tobacco flavour enhancers / casing and top flavours | Flavour formulations that enhance and differentiate the aroma and taste of manufactured cigarettes. Historical R&D included synthesis of a fine natural fragrance for high-end tobacco and two raw-tobacco aroma precursors (FY2014 AR). | Provincial China Tobacco industrial companies (PRC cigarette manufacturers) | Core business since 1990s | Not publicly disclosed (negotiated, procurement-driven) | — |
| Flavours from the Four Businesses (acquired July 2016) | Regional tobacco flavour-enhancer businesses consolidated to raise share and provincial pricing power | Provincial tobacco companies | Acquired 2016 | — | — |
| Tobacco flavours for overseas markets | Management targets overseas diversification under tight PRC compliance | International tobacco customers | Strategic initiative 2025–26 | — | — |
Food flavors segment
| Product line | Description | Target customer | Pricing | Flagship |
|---|---|---|---|---|
| Beverage flavours | Flavour systems for drinks | Beverage manufacturers (PRC and overseas) | — | — |
| Daily food / preserved food flavours | Flavours for processed and preserved foods | Food processors | — | — |
| Savoury flavours | Savoury taste systems | Savoury and snack manufacturers | — | — |
| Confectionery flavours | Sweet flavours | Confectionery makers | — | — |
| Natural-source flavours | Management repeatedly cites developing new flavours from natural resources | Food manufacturers | — | — |
Fine fragrances segment
| Product line | Target customer | Notes |
|---|---|---|
| Cosmetic and perfume fragrances | Cosmetics and perfume manufacturers | Long-standing customer relationships cited as the growth driver (FY2025 AR) |
| Toiletries / soap / hair-care fragrances | Personal-care manufacturers | — |
| Deodorant fragrances | Personal-care manufacturers | — |
| Detergent and air-freshener fragrances | Home-care manufacturers | — |
e-Cigarette products segment
| Product line | Description | Target customer | Notes |
|---|---|---|---|
| Disposable e-cigarettes | Single-use closed devices | Tobacco companies, independent brand owners | PRC national standard compliance required since 1 Oct 2022. Fruit-flavoured products became unsaleable in the PRC, which drove the RMB153.8m e-cigarette receivable impairment in FY2023. |
| Rechargeable e-cigarettes | Pod and closed-system rechargeable devices | Same | Kimree heritage |
| e-Liquids | Nicotine e-liquids | Brand owners; Southeast Asia and developing markets are the promotion priority | Licensed under STMA |
| Accessories | Pods, cartridges, chargers and related items | Same | — |
| OEM / ODM and own-brand manufacturing | Eight subsidiaries hold STMA licences covering e-liquids, own-brand manufacturing (including OEM for clients) and brand-holding | Domestic and global | Licences listed in the 10 Oct 2022 announcement |
| Exclusive manufacturing for the disposed Korean business | Agreements incidental to the 2023 Korea disposal made the Group exclusive manufacturer and supplier of certain e-cigarettes | Mons Co. (Korea) | FY2023 Results |
| Healthcare vaporiser R&D | Research into using vaporiser technology in healthcare | Not commercialised | FY2025 Directors' Report |
Investment properties segment
| Asset | Description | Notes |
|---|---|---|
| Shenzhen Boton Technology Park (Nanshan) | Leased office and industrial space | FY2025 rental revenue RMB59.2m. H1 2026 fell to RMB18.4m (−26.2%) on tenant departures. Management expects new MTR and high-speed rail stations next to the HQ to lift demand. Fair value at 30 Jun 2026: RMB521.1m. |
| Shanghai Fengxian property (pending) | 61,039 sqm industrial building at 88 Chenghebang Road, of which 56,911 sqm is leased | Via the Shanghai Longyin acquisition, not completed at 28 Aug 2026 |
Financial Narrative
All figures in RMB m from the audited consolidated statements in the FY2022, FY2023, FY2024 and FY2025 Annual Results announcements, unless noted. EBITDA is computed as operating profit plus depreciation and amortisation (segment-note D&A). Ratios are analyst computations on year-end balances.
Income statement
Non-recurring items.
-
FY2022 includes a RMB143.1m litigation provision (Kimree vendor loans) and a RMB20.9m investment-property fair-value loss.
-
FY2023 includes a RMB62.8m gain on the Korea disposal and a RMB153.8m e-cigarette receivable impairment.
-
FY2025 includes the RMB845.4m goodwill impairment and a RMB38.2m investment-property fair-value loss.
-
Management's adjusted net profit (excluding goodwill impairment) was RMB130.7m in FY2024 and a loss of RMB154.7m in FY2025.
Margins and growth
Revenue CAGR FY2021–FY2025: −10.1% a year (RMB2,286.1m to RMB1,495.6m). FY2021 growth of 23.4% is from the StockAnalysis/S&P dataset.
Balance sheet
Notes on the balance sheet:
-
FY2025 restricted cash of RMB1,277.5m includes RMB1,136.0m of first-instalment land compensation held in a jointly managed account. It is offset by an equal "compensation received" payable, so it is excluded from net debt. Including it, FY2025 net debt would be RMB600.2m.
-
Goodwill is not separately broken out in the announcements reviewed. The FY2025 fall in intangibles from RMB1,615.4m to RMB733.8m reflects mainly the RMB845.4m goodwill impairment.
Post-period balance sheet (30 Jun 2026, H1 2026 Interim).
-
Cash RMB1,452.2m and restricted cash RMB118.5m, against borrowings of RMB1,164.7m (current RMB250.5m, non-current RMB914.3m). This is net cash of RMB406.0m.
-
Total equity was RMB2,413.1m, of which owners RMB2,021.6m.
-
Gearing (borrowings/equity) fell to 48.3% from 92.1%.
-
The full RMB2,494.4m compensation sat in "other payables" pending completion in July 2026. The disposal gain will therefore be recognised in H2 2026. The company's December 2025 announcement estimated an unaudited pre-tax gain of about RMB2,380.7m (including the early-completion bonus) and net proceeds of about RMB1,768.4m, as reported by FilingReader on 9 Dec 2025.
Cash flow
Source: StockAnalysis / S&P Global Market Intelligence, standardised from company cash flow statements. Capex figures differ slightly from MD&A "investment in fixed assets and CIP" (FY2023 MD&A RMB160.7m; FY2024 RMB544.9m; FY2025 RMB377.7m).
The company declared no dividends to its own shareholders in FY2021–FY2025, so the "dividends paid" line reflects distributions within subsidiaries to minorities. The FY2024 buyback relates to 500,000 shares bought by the share award trustee. In H1 2026 the company repurchased 5,572,000 shares for HK$12.99m. By 11 Sep 2026 treasury shares totalled 25,818,000 (H1 2026 Interim; FF305 returns).
Commentary on trends, inflections and drivers
Revenue. FY2021 was the peak (RMB2,286.1m), driven by e-cigarettes, which made up 53% of sales, and a 23.4% surge on Korean and export demand. The inflection came with China's 2022 e-cigarette regulation: STMA licensing plus the 1 October 2022 national standard banning non-tobacco flavours. E-cigarette revenue fell 22.6% in FY2023 and 29.1% in FY2024. Tobacco flavours, the second pillar, began declining in FY2023 (−3.4%) and accelerated to −21.7% in FY2024 and −36.2% in FY2025. Management attributes this to procurement-policy adjustments and customers' in-house flavour development. The H1 2026 rebound (+25.3%) is entirely e-cigarette and food-flavour led; tobacco flavours fell another 7.9%.
Gross margin. Margin was resilient at 36–39% through FY2024, helped by mix (the Korean nicotine tax line disappeared after the 2023 disposal). It then collapsed to 25.2% in FY2025 as tobacco-flavour volume fell against a fixed cost base. Raw-material and labour inflation and inventory write-downs (RMB15.8m) added to the pressure. H1 2026 gross margin was 29.2% (233.1/798.8).
Operating costs. Administrative expenses rose to 24.7% of revenue in FY2025. Drivers were outsourced R&D consulting (consulting and commission fees doubled to RMB61.5m) and utilities at the new Huizhou plant. The opex base appears sized for a RMB2bn+ revenue company.
Balance sheet. The defining feature through FY2024 was rising leverage with weak cash conversion. Capex of RMB904.6m across FY2024–FY2025 (Huizhou e-vaporiser base and tobacco-flavour upgrades) was largely debt-funded, and debt reached RMB2.2bn by end-FY2025. Receivables quality is poor: trade receivables over one year old were RMB275.6m at end-FY2025, almost entirely provided (ECL RMB243.9m).
The land resumption resets everything. RMB1.25bn of the proceeds was earmarked for debt repayment. Borrowings duly fell by RMB1,037.5m in H1 2026, and the group moved to net cash.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Key entities (as disclosed) |
|---|---|---|
Tobacco flavors (renamed in FY2025 from "Flavor enhancers") | Flavour formulations and enhancers for combustible cigarette manufacturers; includes the Four Businesses acquired in July 2016 | Shenzhen Boton Flavors & Fragrances Co., Ltd.; Hubei Boton Biological Technology Co., Ltd. |
Food flavors | Flavours for beverages, daily foods, preserved food, savoury and confectionery | Boton Flavors and Fragrances Co., Ltd. (formerly Dongguan Boton) |
Fine fragrances | Fragrances for cosmetics, perfumes, soaps, toiletries, hair care, deodorants, detergents and air fresheners | Dongguan Boton |
e-Cigarette products | Disposable and rechargeable e-cigarettes, e-liquids and accessories (OEM/ODM and brand-holding) | Kimree group (Huizhou Kimree Technology; Kimsun Technology (Huizhou)); Huizhou Babo Technology; Kimree Technology (HK) |
Investment properties | Leasing of office and industrial space at the Shenzhen Boton Technology Park | Shenzhen Boton |
Segment revenue (CNY Mn)
| Segment revenue (CNY Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Tobacco flavors (CNY Mn) | 729.2 | 795.9 | 768.6 | 602.0 | 384.1 |
Food flavors (CNY Mn) | 165.5 | 171.7 | 182.0 | 190.4 | 206.0 |
Fine fragrances (CNY Mn) | 138.3 | 149.8 | 165.8 | 169.8 | 177.5 |
e-Cigarette products (CNY Mn) | 1,213.4 | 1,164.9 | 901.6 | 639.6 | 668.8 |
Investment properties (CNY Mn) | 39.7 | 42.5 | 45.7 | 51.3 | 59.2 |
Total revenue (CNY Mn) | 2,286.1 | 2,324.8 | 2,063.7 | 1,653.0 | 1,495.6 |
Segment YoY growth (%)
| Segment YoY growth (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Tobacco flavors YoY (%) | 9.1 | -3.4 | -21.7 | -36.2 |
Food flavors YoY (%) | 3.7 | 6.0 | 4.6 | 8.2 |
Fine fragrances YoY (%) | 8.3 | 10.7 | 2.4 | 4.5 |
e-Cigarette products YoY (%) | -4.0 | -22.6 | -29.1 | 4.6 |
Investment properties YoY (%) | 7.1 | 7.5 | 12.1 | 15.5 |
Segment share of revenue (%)
| Segment share of revenue (%) | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
Tobacco flavors share (%) | 31.9 | 34.2 | 37.3 | 36.4 |
Food flavors share (%) | 7.2 | 7.4 | 8.8 | 11.5 |
Fine fragrances share (%) | 6.1 | 6.5 | 8.0 | 10.3 |
e-Cigarette products share (%) | 53.1 | 50.1 | 43.7 | 38.7 |
Investment properties share (%) | 1.7 | 1.8 | 2.2 | 3.1 |
Segment profit before tax (CNY Mn)
| Segment profit before tax (CNY Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Tobacco flavors PBT (CNY Mn) | 179.0 | 167.0 | 187.3 | 35.8 | -981.9 |
Food flavors PBT (CNY Mn) | 48.6 | 48.7 | 45.0 | 55.4 | 64.7 |
Fine fragrances PBT (CNY Mn) | 13.1 | 17.5 | 41.8 | 46.6 | 43.2 |
e-Cigarette products PBT (CNY Mn) | 93.7 | 33.6 | -75.0 | -53.9 | -131.0 |
Investment properties PBT (CNY Mn) | 11.9 | -0.3 | 18.7 | 27.3 | 14.3 |
Unallocated PBT (CNY Mn) | -43.8 | -154.3 | -34.3 | -25.7 | -21.5 |
Group PBT (CNY Mn) | 302.5 | 112.2 | 183.5 | 85.7 | -1,012.1 |
Segment PBT margin (%)
| Segment PBT margin (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Tobacco flavors PBT margin (%) | 24.5 | 21.0 | 24.4 | 5.9 | -255.6 |
Food flavors PBT margin (%) | 29.4 | 28.4 | 24.7 | 29.1 | 31.4 |
Fine fragrances PBT margin (%) | 9.5 | 11.7 | 25.2 | 27.4 | 24.3 |
e-Cigarette products PBT margin (%) | 7.7 | 2.9 | -8.3 | -8.4 | -19.6 |
Investment properties PBT margin (%) | 30.0 | -0.7 | 40.9 | 53.2 | 24.2 |
Segment capex (CNY Mn)
| Segment capex (CNY Mn) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Tobacco flavors capex (CNY Mn) | 29.7 | 27.6 | 141.6 | 203.3 |
Food flavors capex (CNY Mn) | 4.7 | 4.5 | 3.0 | 0.7 |
Fine fragrances capex (CNY Mn) | 0.9 | 0.8 | 2.4 | 1.0 |
e-Cigarette products capex (CNY Mn) | 134.8 | 127.8 | 402.6 | 214.4 |
Revenue by Segment
| Segment D&A (CNY Mn) | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
Tobacco flavors D&A (CNY Mn) | 80.5 | 80.1 | 54.9 | 61.9 |
Food flavors D&A (CNY Mn) | 6.4 | 5.1 | 14.9 | 7.5 |
Fine fragrances D&A (CNY Mn) | 6.7 | 6.3 | 15.0 | 7.3 |
e-Cigarette products D&A (CNY Mn) | 23.2 | 22.9 | 39.8 | 36.3 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment (Half-Yearly)
| Segment (six months, CNY Mn) | H1 2025 | H1 2026 |
|---|---|---|
e-Cigarette products revenue (CNY Mn) | 267.2 | 422.5 |
Tobacco flavors revenue (CNY Mn) | 179.5 | 165.2 |
Food flavors revenue (CNY Mn) | 93.1 | 115.6 |
Fine fragrances revenue (CNY Mn) | 73.1 | 77.2 |
Investment properties revenue (CNY Mn) | 24.9 | 18.4 |
e-Cigarette products PBT (CNY Mn) | -20.2 | -20.8 |
Tobacco flavors PBT (CNY Mn) | -35.2 | -21.8 |
Food flavors PBT (CNY Mn) | 26.0 | 36.4 |
Fine fragrances PBT (CNY Mn) | 17.2 | 20.9 |
Investment properties PBT (CNY Mn) | 24.5 | 13.5 |
Income statement (CNY Mn)
| Income statement (CNY Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (CNY Mn) | 2,286.1 | 2,324.8 | 2,063.7 | 1,653.0 | 1,495.6 |
Cost of sales (CNY Mn) | 1,393.8 | 1,537.9 | 1,265.6 | 1,055.1 | 1,118.5 |
Gross profit (CNY Mn) | 892.3 | 786.9 | 798.1 | 597.9 | 377.1 |
Selling and marketing expenses (CNY Mn) | 144.2 | 102.1 | 108.8 | 48.5 | 65.8 |
Administrative expenses (CNY Mn) | 359.0 | 359.4 | 342.6 | 334.7 | 369.6 |
Goodwill impairment (CNY Mn) | 0.0 | 0.0 | 0.0 | 67.4 | 845.4 |
Net impairment on financial assets (CNY Mn) | 30.5 | 13.4 | 156.9 | 7.6 | 21.7 |
Operating profit (CNY Mn) | 360.0 | 158.1 | 249.0 | 149.0 | -961.0 |
Depreciation and amortisation (CNY Mn) | 136.3 | 133.8 | 132.1 | 120.8 | 142.6 |
EBITDA (CNY Mn) | 496.3 | 291.9 | 381.1 | 269.8 | -818.4 |
EBITDA excl. goodwill impairment (CNY Mn) | 496.3 | 291.9 | 381.1 | 337.2 | 27.0 |
Finance costs (CNY Mn) | 61.4 | 62.4 | 73.0 | 65.9 | 63.6 |
Profit before tax (CNY Mn) | 302.5 | 112.2 | 183.5 | 85.7 | -1,012.1 |
Income tax expense (CNY Mn) | 77.0 | 27.7 | 42.8 | 22.4 | -12.0 |
Net profit (CNY Mn) | 225.6 | 84.5 | 140.6 | 63.3 | -1,000.1 |
Net profit attributable to owners (CNY Mn) | 183.5 | 48.3 | 146.4 | 18.4 | -1,031.9 |
Non-controlling interests (CNY Mn) | 42.0 | 36.2 | -5.7 | 44.9 | 31.7 |
Basic EPS (MYR Bn) | 0.17 | 0.04 | 0.14 | 0.02 | -0.96 |
Diluted EPS (MYR Bn) | 0.17 | 0.04 | 0.14 | 0.02 | -0.96 |
Dividend per share (MYR Bn) | 0 | 0 | 0 | 0 | 0 |
Margins and growth (%)
| Margins and growth (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue growth (%) | 23.4 | 1.7 | -11.2 | -19.9 | -9.5 |
Gross margin (%) | 39.0 | 33.8 | 38.7 | 36.2 | 25.2 |
Operating margin (%) | 15.7 | 6.8 | 12.1 | 9.0 | -64.3 |
EBITDA margin (%) | 21.7 | 12.6 | 18.5 | 16.3 | -54.7 |
EBITDA margin excl. goodwill impairment (%) | 21.7 | 12.6 | 18.5 | 20.4 | 1.8 |
Net margin (%) | 9.9 | 3.6 | 6.8 | 3.8 | -66.9 |
Balance Sheet
| Balance sheet (CNY Mn, 31 Dec) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (CNY Mn) | 6,311.6 | 6,451.0 | 6,006.9 | 6,297.9 | 6,798.9 |
Cash and cash equivalents (CNY Mn) | 330.5 | 433.0 | 349.8 | 282.7 | 324.6 |
Pledged / restricted deposits (CNY Mn) | 201.4 | 273.7 | 260.6 | 183.5 | 1,277.5 |
Short-term borrowings incl. current portion (CNY Mn) | 706.3 | 917.5 | 859.1 | 894.1 | 943.3 |
Long-term borrowings (CNY Mn) | 689.6 | 748.3 | 696.2 | 955.9 | 1,259.0 |
Total borrowings (CNY Mn) | 1,396.0 | 1,665.9 | 1,555.3 | 1,850.0 | 2,202.3 |
Net debt excl. land escrow (CNY Mn) | 864.1 | 959.2 | 944.9 | 1,383.8 | 1,736.2 |
Total equity (CNY Mn) | 3,169.6 | 3,262.1 | 3,376.2 | 3,409.3 | 2,391.3 |
Equity attributable to owners (CNY Mn) | 2,913.0 | 2,975.7 | 3,127.2 | 3,141.0 | 2,102.7 |
Intangible assets incl. goodwill (CNY Mn) | 1,817.8 | 1,768.9 | 1,721.6 | 1,615.4 | 733.8 |
Property, plant and equipment (CNY Mn) | 1,499.3 | 1,499.0 | 1,528.9 | 1,993.6 | 2,265.4 |
Investment properties (CNY Mn) | 547.9 | 637.0 | 632.0 | 631.8 | 522.1 |
Working capital (CNY Mn) | 138.8 | 189.3 | 100.6 | 46.7 | 27.1 |
Cash flow (CNY Mn)
| Cash flow (CNY Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (CNY Mn) | 277.2 | 129.8 | 214.4 | 188.7 | 88.7 |
Capital expenditure (CNY Mn) | 111.2 | 169.6 | 118.0 | 526.3 | 378.3 |
Free cash flow (CNY Mn) | 166.1 | -39.9 | 96.4 | -337.6 | -289.6 |
Dividends paid, mainly to non-controlling interests (CNY Mn) | 0.0 | 0.0 | 0.0 | 34.9 | 9.1 |
Share buybacks (CNY Mn) | 0.0 | 0.0 | 0.0 | 1.0 | 0.0 |
Cash interest paid (CNY Mn) | 55.1 | 58.8 | 61.7 | 65.0 | 63.7 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratios | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE on attributable year-end equity (%) | 6.3 | 1.6 | 4.7 | 0.6 | -49.1 |
ROA (%) | 3.6 | 1.3 | 2.3 | 1.0 | -14.7 |
ROIC, NOPAT at 15% tax / (equity + debt) (%) | 6.7 | 2.7 | 4.3 | 2.4 | -17.8 |
Current ratio (x) | 1.07 | 1.09 | 1.06 | 1.03 | 1.01 |
Debt to equity (%) | 44.0 | 51.1 | 46.1 | 54.3 | 92.1 |
Net debt to EBITDA (x, FY2025 on EBITDA excl. impairment) | 1.74 | 3.29 | 2.48 | 5.13 | 64.3 |
Interest coverage, operating profit / finance costs (x) | 5.86 | 2.53 | 3.41 | 2.26 | -15.11 |
Asset turnover (x) | 0.36 | 0.36 | 0.34 | 0.26 | 0.22 |
Days sales outstanding (days) | 164 | 130 | 86 | 103 | 119 |
Days inventory outstanding (days) | 58 | 86 | 95 | 117 | 82 |
Days payables outstanding (days) | 208 | 132 | 105 | 150 | 125 |
Cash conversion cycle (days) | 14 | 84 | 76 | 70 | 76 |
Geographic revenue (CNY Mn)
| Geographic revenue (CNY Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
PRC (CNY Mn) | 1,928.0 | 1,781.7 | 1,417.0 | 1,363.8 | 1,134.2 |
Asia ex-PRC (CNY Mn) | 345.5 | 525.1 | 624.6 | 287.2 | 358.8 |
Others incl. Europe and US (CNY Mn) | 12.6 | 18.0 | 22.2 | 2.0 | 2.6 |
Total (CNY Mn) | 2,286.1 | 2,324.8 | 2,063.7 | 1,653.0 | 1,495.6 |
Geographic growth (%)
| Geographic growth (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
PRC YoY (%) | -7.6 | -20.5 | -3.8 | -16.8 |
Asia ex-PRC YoY (%) | 52.0 | 18.9 | -54.0 | 24.9 |
Geographic share (%)
| Geographic share (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
PRC share (%) | 84.3 | 76.6 | 68.7 | 82.5 | 75.8 |
Asia ex-PRC share (%) | 15.1 | 22.6 | 30.3 | 17.4 | 24.0 |
Others share (%) | 0.6 | 0.8 | 1.1 | 0.1 | 0.2 |
Share price proxy
| Share price proxy | Jan-2022 | Jan-2023 | Jan-2024 | Jan-2025 | Jan-2026 |
|---|---|---|---|---|---|
Start-of-year share price (HKD) | 3.83 | 2.72 | 1.22 | 1.44 | 1.78 |
Start-of-year market cap (HKD Bn) | 4.14 | 2.94 | 1.32 | 1.56 | 1.92 |
Performance to 8 Oct 2026 (price HK$3.005) | Value | — | — | — | — |
YTD 2026 | About +69% from the derived HK$1.78 (MarketScreener showed +75.1% YTD at 8 Sep 2026, at HK$3.03) | — | — | — | — |
1-year | About +70% (HK$1.77 on 31 Oct 2025 per TipRanks) | — | — | — | — |
~3-year (from Jan 2024) | About +146% | — | — | — | — |
~5-year (from Jan 2022) | About −22% | — | — | — | — |
52-week range | HK$1.05 – HK$3.04 (MarketScreener, 8 Sep 2026) | — | — | — | — |
10-year high | HK$13.4 (MarketScreener) | — | — | — | — |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
Enterprise value | About RMB2,741m | Market cap − net cash + NCI (excludes RMB243.3m FVTPL assets) |
EV/Sales (TTM) | About 1.65x | TTM revenue RMB1,656.6m (FY2025 − H1 2025 + H1 2026) |
P/B (reported) | About 1.36x | Owners' equity RMB2,021.6m at 30 Jun 2026 |
P/B (pro forma, analyst estimate) | About 0.7–0.8x | Assumes a post-tax land gain of roughly RMB1.7–1.8bn is recognised in H2 2026. Indicative only, not company guidance. |
Capital returns
| Capital returns | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividend per share (MYR Bn) | 0 | 0 | 0 | 0 | 0 |
Shares repurchased (m shares) | 0 | 0 | 0 | 0.5 | 0 |
Capital Markets
| Item | Detail |
|---|---|
Moody's / S&P / Fitch | Not rated |
Debt at 30 Jun 2026 | RMB1,164.7m in total: current RMB250.5m; non-current RMB914.3m. RMB1,006.0m in RMB, RMB158.7m in HKD. |
Interest rates (H1 2026) | Short-term 3.0–4.7%; long-term 2.8–5.4%. Effective rate at end-FY2025: 3.01%. |
Security | PP&E RMB1,219.5m; investment properties RMB521.1m; deposits RMB118.5m; land use rights RMB38.9m; 100% equity pledge of Shenzhen Boton; personal guarantee of Wang Ming Fan; corporate guarantees |
Detailed maturity ladder | Not publicly disclosed in the interim announcement |
Analyst Conclusions
Management guidance
There is no numerical guidance. Qualitatively, management expects:
-
greater regulatory rigour in e-cigarettes and tobacco flavours, met through compliance, innovation and market diversification;
-
the land resumption proceeds to improve liquidity and fund R&D and e-cigarette expansion;
-
improved Shenzhen leasing as new transport infrastructure opens (H1 2026 Interim).
Consensus
There is no consensus because there is no sell-side coverage.
FY2026 mechanical expectation (analyst view). Reported FY2026 earnings will be dominated by recognition of the land resumption gain in H2 2026. The company estimated about RMB2.38bn pre-tax. Underlying operations ran at roughly breakeven in H1 2026 (group PBT RMB12.4m; attributable loss RMB30.0m).
Bull case
-
Balance-sheet transformation creates optionality. The group moved from RMB1,736m net debt (ex-escrow, end-FY2025) to RMB406m net cash (30 Jun 2026), with interest savings on about RMB1bn of repaid debt. Finance costs could roughly halve from about RMB64m a year. Disciplined deployment or a special distribution could unlock value well above the current RMB2.76bn market cap.
-
E-cigarette volume recovery plus new capacity. H1 2026 e-cigarette revenue rose 58.1% to RMB422.5m on new domestic customers, and the Huizhou plant now offers automated capacity. If losses narrow as utilisation rises, the segment could swing to profit. Management cites partnership talks with significant players.
-
Hidden quality in F&F. Food and fine fragrances produced RMB107.9m PBT in FY2025 and RMB57.3m in H1 2026 (+33% YoY), at roughly 28–31% margins. A revived A-share spin-off of Dongguan Boton could crystallise a value disconnected from the group's tobacco-linked discount.
Bear case
-
Core businesses are value-destructive. Excluding goodwill, the FY2025 net loss was RMB154.7m. E-cigarette PBT stayed negative even after a 58% revenue rise in H1 2026, and tobacco flavours remain in structural decline (−7.9% in H1 2026) against monopsony customers that are internalising flavour development.
-
Governance and capital-allocation risk. With 67.5% founder control, a combined Chair/CEO, a family-member Group FC, interest-free related-party advances and a RMB240m property purchase immediately after the windfall, minorities may not capture the land value. Owners' share of profits is also diluted by rising NCI in Dongguan Boton.
-
Earnings quality and cash conversion. Operating cash flow has fallen every year since FY2023 (RMB214.4m to RMB88.7m in FY2025, and RMB40.5m TTM to Jun 2026). Receivables over one year old are about 37% of gross trade receivables. Opex at 25%+ of revenue leaves no buffer for further regulatory shocks.
Catalysts and monitorables (next 12 months)
-
FY2026 annual results (expected around March 2027): size of the land gain, tax charge, and any special or final dividend declaration.
-
Completion of the Shanghai Longyin acquisition (remaining RMB80m), and any further property or M&A deployments.
-
Pace and size of share buybacks; any cancellation of treasury shares.
-
E-cigarette segment margin trajectory and Huizhou utilisation; any announced partnership with a significant industry player.
-
Tobacco-flavour revenue stabilisation, or further impairment of residual intangibles (RMB718.1m at 30 Jun 2026).
-
Kimree litigation: the PRC appellate ruling on damages and the RMB150m consideration claim.
-
Any revival of the Dongguan Boton A-share spin-off.
-
PRC and overseas e-cigarette regulatory changes (taxation, flavour rules, export markets).
Analyst verdict
China Boton enters late 2026 as a company whose balance sheet has outrun its business. The Shenzhen land resumption delivered RMB2.49bn of cash against a book value near RMB114m. It turned a leveraged, cash-thin group with 92% gearing into one with RMB406m of net cash. Once the expected roughly RMB2.4bn pre-tax gain is booked in H2 2026, retained earnings should be rebuilt. The equity market has already reacted: the shares have roughly doubled from their pre-announcement level to about HK$3.0. On reported book the stock trades near 1.4x; on a pro forma basis, analyst estimates suggest perhaps 0.7–0.8x book.
The operating franchise is weaker than the headline recovery implies. Tobacco flavours, once the profit anchor, lost money before impairment in FY2025 and continued to shrink in H1 2026. The PRC buyers that dominate this market are internalising formulation, a structural rather than cyclical threat. The e-cigarette business has regained revenue but not profitability, and it competes against a scale leader with roughly twenty times its revenue. Only food flavours and fine fragrances are genuinely healthy, and minorities in Dongguan Boton capture a growing share of their earnings.
The investment case therefore rests almost entirely on capital allocation, under a governance structure that offers minority shareholders limited protection. Buybacks are a positive signal. The RMB240m Shanghai property acquisition shows the cash may also be steered into real estate rather than returned. Without coverage, guidance or targets, visibility is low.
The analyst stance is neutral, with event-driven upside. The stock is a reasonable special-situation holding for investors who expect a meaningful special dividend or a spin-off of the F&F unit. Without such a catalyst, the underlying business does not justify a premium, and the post-windfall rally leaves limited margin of safety.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Since | Age (FY2025 AR) | Background | Education |
|---|---|---|---|---|---|
Wang Ming Fan (王明凡), MH, JP | Chairman (since 25 Oct 2012), CEO and Executive Director (since Apr 2005) | Joined Group 1996 | 59 | 30+ years in F&F. Previously deputy GM of Shenzhen Lianhai Chemical Industrial (about 10 years). Member of the 14th CPPCC National Committee; HKSAR Medal of Honour (2015); JP (2024). | — |
Li Qing Long (李慶龍) | Executive Director (since Apr 2005); VP of Shenzhen Boton; responsible for F&F R&D and production | Joined Mar 1991 | 65 | Previously about 8 years at Shanghai Flavor and Fragrance Factory | Shanghai Light Industry Professional School, 1982 (organic synthesis) |
Wang Xinyi (王心怡) | Executive Director and Group Financial Controller (since 1 Apr 2025) | 2025 | 28 | Chairman's daughter. US tax consulting associate at PwC (Sep 2022 – Jan 2025). CPPCC Shenzhen Nanshan member. | BS, Penn State (2020); Master of Management in Accounting, Cornell |
Leung Wai Man, Roger (梁偉民) | INED; Chair of Nomination Committee | Nov 2005 | 69 | HK solicitor since 1984; Senior Consultant at a law firm; INED of Hi Sun Technology (818) | LLB, HKU; JD, Western Ontario |
Zhou Xiao Xiong (周小雄) | INED | Nov 2005 | 65 | Senior roles at Guangdong Securities, Bank of China, Zhongshan Securities and J.P. Morgan Futures (China) | Renmin University; MBA Tsinghua |
Ng Kwun Wan (吳冠雲) | INED; Chair of Audit and Remuneration Committees | Dec 2009 | 62 | HKICPA; formerly New World Development (China); INED of 351, 3737 and 8616 | Manchester Polytechnic; MCom, UNSW |
Yau How Boa (邱浩波), GBS, JP | INED | Apr 2023 | 74 | Former Wanchai District Councillor; numerous public-service boards; Chief Executive of International Social Service HK Branch | LLB Peking University; LLM CityU; MSW (US) |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
29 Dec 2023 | Wan Shuk Ching, Candy appointed NED | Addressed HKEX single-gender board prohibition (Rule 13.92) |
1 Apr 2025 | Wang Xinyi appointed ED and Group FC | Succession and family representation; also restored board gender diversity ahead of Ms. Wan's exit |
30 Jun 2025 | Yang Ying Chun resigned as ED | ED since 5 Jan 2018; no service contract |
30 Nov 2025 | Wan Shuk Ching, Candy resigned as NED | Board reduced to 7 |
Apr and Dec 2025 | INED service agreements renewed for two years (Yau in Apr 2025; Leung, Ng and Zhou on 17 Dec 2025) | — |
Major Shareholders
| Holder | Shares | % of issued | Nature |
|---|---|---|---|
Wang Ming Fan (aggregate) | 729,456,226 | 67.51 | Personal, family and corporate |
of which personal | 336,555,052 | 31.15 | Beneficial |
of which Creative China Limited | 348,320,509 | 32.24 | Owned 41.19% by Wang Ming Fan, 28.11% Wong Ming Bun, 10.01% Wang Ming Qing, 9.86% Wang Ming You, 6.89% Qian Wu, 3.94% Li Qing Long |
of which Full Ashley Enterprises Limited | 19,318,234 | 1.79 | 100% Wang Ming Fan |
of which Yang Yifan (spouse) | 25,262,431 | 2.34 | Family interest |
Treasury shares (11 Sep 2026) | 25,818,000 | 2.39 | Company |
Share award trust | 500,000 | 0.05 | Tricor Trust |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Listing | Positioning vs China Boton | Data status |
|---|---|---|---|---|
e-Cigarettes | Smoore International (思摩爾) | 6969.HK | Global leader in vaping hardware (CCELL, VAPORESSO) and HNB. FY2025 revenue RMB14,256m, about 21x China Boton's FY2025 e-cigarette revenue. | Verified (Smoore FY2025 results) |
e-Cigarettes | Ispire Technology | NASDAQ: ISPR | Shenzhen-manufactured vaping hardware OEM | — |
e-Cigarettes | Shenzhen-cluster OEMs (e.g., Innokin, Geekvape) | Private | Branded and OEM devices | — |
e-Cigarettes | Former Kimree founders' businesses | Private | Alleged breach of non-compete (HK litigation since 2020) | Litigation-based |
Tobacco flavours | Huabao International (華寶國際) | 0336.HK | Largest listed PRC flavour house with heavy tobacco exposure. FY2025 revenue RMB3,484.7m; gross margin 40.8%; operating loss RMB360.9m. | Verified (Huabao FY2025 results) |
Tobacco flavours | Customers' in-house flavour units (provincial China Tobacco companies) | State-owned | Explicitly cited by management as a revenue headwind ("self-developed tobacco flavors") | FY2025 AR |
Tobacco flavours | Apple Flavor & Fragrance Group (愛普股份) | 603020.SS | PRC flavour and fragrance producer | — |
Tobacco flavours / packaging | Shenzhen Jinjia Group (勁嘉股份) | 002191.SZ | Tobacco packaging plus new-tobacco and flavour adjacencies | — |
F&F (food, fine fragrance) | Givaudan | SIX: GIVN | Global #1. FY2025 sales CHF7,472m; EBITDA margin 23.4%. | Verified (Givaudan FY2025 results) |
F&F | International Flavors & Fragrances (IFF) | NYSE: IFF | Global top-3 | — |
F&F | dsm-firmenich | Euronext: DSFIR | Global top-3 | — |
F&F | Symrise | XETRA: SY1 | Global top-5 | — |
“—” = not publicly disclosed.
Peer Comparison FY2025
| Metric (FY2025) | China Boton | Smoore International | Huabao International | Givaudan |
|---|---|---|---|---|
Revenue | RMB1,495.6m | RMB14,256m | RMB3,484.7m | CHF7,472m |
Revenue growth | −9.5% | +20.8% | +3.3% | +5.1% LFL |
Gross margin | 25.2% | 34.1% | 40.8% | 43.5% |
EBITDA margin | −54.7% (1.8% ex-impairment) | — | −0.2% | 23.4% |
Net margin | −66.9% | About 7.4% | — | 14.3% |
R&D intensity | Not disclosed (3.4% in FY2022) | — | — | — |
Recent Developments
--



